March 13, 2025
Enhanced Cardiovascular Care Available to New Brunswick Patients Thanks to Horizon, Amgen Canada Research Partnership
March 4, 2024
WEZLANA™ (Ustekinumab), a Biosimilar to STELARA®, Now Available in Canada for Certain Chronic Inflammatory Diseases
January 24, 2024
Amgen British Columbia Completes State of the Art Lab Expansion
No current content.